Dysregulation of MYC has also been shown to be involved in genome instability,18 where MYC amplification has been reported to be closely linked to ERBB2 proto‐oncogene (mapped to 17q12) amplification to strongly activate cell proliferation in breast cancer.19 This evidence concerns the gene ERBB2 and breast cancer.